Navigation Links
CIGNA HealthCare of Arizona and Catholic Healthcare West Reach Agreement
Date:5/9/2008

is one of the oldest and largest health plans in the state. CIGNA HealthCare of Arizona provides health care coverage and employee benefit services to nearly 350,000 individuals throughout the state. CIGNA Medical Group, the medical group practice division of CIGNA HealthCare of Arizona, is one of the Valley's largest multi-specialty group practices with 21 offices located throughout metropolitan Phoenix. "CIGNA HealthCare" refers to various operating subsidiaries of CIGNA Corporation (NYSE: CI). Products and services are provided by these operating subsidiaries and not by CIGNA Corporation.

About Catholic Healthcare West

Catholic Healthcare West (CHW) is the eighth largest hospital system in the nation and the largest not-for-profit hospital provider in the West. Founded in 1986, the CHW network of more than 9,500 physicians and approximately 53,000 employees serve a population spanning 22 million people at 41 hospitals across California, Arizona, and Nevada. CHW is committed to delivering compassionate, high-quality, affordable healthcare services with special attention to the poor and underserved. In 2007, CHW provided $922 million in charity care, community benefits, and unreimbursed patient care.


'/>"/>
SOURCE CIGNA HealthCare of Arizona
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. VIDEO from Medialink and CIGNA: Hope Binders Help Parents in the Battle Against Life-Threatening Diseases in Children
2. Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011
3. Gordon & Rees LLP Joins ArlenGroup-CIGNA Health Care Purchasing Consortium
4. RNs Statement on Death of Nataline Sarkisyan: CIGNA Should Have Listened to her Doctors and Approved the Transplant a Week Ago
5. CIGNA Capitulates to Patient Revolt
6. ICMA/CIGNA Survey: U.S. Cities and Counties Begin to Focus on Health Risks and Costs
7. CIGNA Behavioral Health Offers Members Online Provider Profiles
8. CIGNA HealthCare Continues Gains in Health Care Quality
9. CIGNA Group Insurance Celebrates Return to Work Success During National Rehabilitation Awareness Week
10. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
11. Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/13/2008)... Temperature Stable Treatment for Hemophilia With ...ence to Patients, PRINCETON, N.J., May 13 /PRNews...at the US Food and Drug Administration (FDA) has a...Recombinant] Room Temperature,Stable), the first r...le,for the treatment of bleeding episodes in patie...
(Date:5/13/2008)... on electronic bingo to fulfill the unmet needs of...mmunities, SACRAMENTO, Calif., May 13 /PRNewswire...nnounced its formation to advocate for the use of,...bingo as a responsible,legal and consistent fundi...zations for this new alliance include Disabled Spo...
(Date:5/13/2008)...ration Among 52 Companies Recognized for Promoting...LE GROVE, Minn., May 13 /PRNewswire/ -- The Nation... organization of large employers, today,honored Da...t and,dedication to promoting a healthy workplace ...ees and families., (Logo: http://www.newscom.com...
(Date:5/13/2008)... rental revenue increase 12.0 percent demonstratin...l-Rom reporting for first time since separation; s...owing results, - Management updates financial guid... and operational momentum, BATESVILLE,...oldings,Inc. (NYSE: HRC ), reporting for the fir...
Breaking Medicine News(10 mins):Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 2Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 3Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 4Health News:Charities Form Alliance to Preserve and Improve Charity Bingo 2Health News:National Business Group on Health Honors Data Recognition Corporation as One of Best Employers for Healthy Lifestyles 2Health News:National Business Group on Health Honors Data Recognition Corporation as One of Best Employers for Healthy Lifestyles 3Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 2Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 3Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 4Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 5Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 6Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 7Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 8Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 9Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 10Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 11Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 12Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 13Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 14
...dical Officer of Ontario has announced that it wil...jor infectious disease outbreak. Many of Ontario's... working on a full time basis,// and provincial la... outdated equipment. The Province may be incapable...
...entists have revealed that men can be more vindict...ile women generally feel empathy when they feel sl...s of the study were published in the Nature journa... the study, which proves that the sex of the perso...
...d was declared brain dead in a hospital in Hyderab...e organs of their loved one. // MOHAN (Multi Organ...ere called in and they provided the family with em...ere being undertaken. It was late evening before a...
...lk Center at India’s Mumbai City has been providin...Center at the Sion Hospital caters// to newborns ... The deprivation of breast milk, which contains a ... digestible food for babies, could lead to lower I...
Other Medicine News:Health News:A first in Liver Transplant in India – Networking works wel 2Health News:Human Milk Center Caters To Premature Babies 2
(Date:5/13/2008)...3 /- USHIFU, LLC, the clinical trial,...napolis, IN), is pleased,to announce conditional w...col from the FDA to begin a pivotal trial for the ...nablate(R) 500 in men who have failed,external bea... of Urology at NYU School of Medicine and,medical ...
(Date:5/13/2008)...rance, May 13 /- NicOx S.A.... Inc. has initiated the,first in a series of plann...ive patients, under the companies, collaborative a...hypertensive agents using NicOx,proprietary techn...d from,the companies, joint research program, of w...
(Date:5/12/2008)..., Calif., May 12 /- Napo,Ph...es that it presented a,poster in collaboration wit...f a patient reported outcomes questionnaire focuse...spects of chronic diarrhea in persons living with,...rmacoeconomics and,Outcomes Research (ISPOR) Annua...
(Date:5/12/2008)...rcell,) to acquire Iomai Corporation (,Iomai,) in ...D 6.60 per share of Iomai,s common stock represe...pproximately USD 189 million (EUR 122 million). Ac...ock exchange for approximately 41 percent of Ioma...holders for,approximately 1.7 million Intercell sh...
Breaking Medicine Technology:FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer 2NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 2NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 3Napo Presents at ISPOR Meeting in Toronto 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 3Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 4Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 6Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 7Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 8Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 9Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 10Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 11LifeScience Alley 2007 3A German Healthcare Market Offers Gateway to Europe 7736 1LifeScience Alley 2007 3A German Healthcare Market Offers Gateway to Europe 7736 2Edison Innovation Fund Helps Tris Pharma Expand 2093 1Edison Innovation Fund Helps Tris Pharma Expand 2093 2Edison Innovation Fund Helps Tris Pharma Expand 2093 3Alpha 1 Foundation AARC Cooperate on Study to Test 5 000 COPD Patients for Alpha 1 995 1Alpha 1 Foundation AARC Cooperate on Study to Test 5 000 COPD Patients for Alpha 1 995 2Alpha 1 Foundation AARC Cooperate on Study to Test 5 000 COPD Patients for Alpha 1 995 3Common Household Chemical Could Raise Breast Cancer Risk 7733 1Common Household Chemical Could Raise Breast Cancer Risk 7733 2Common Household Chemical Could Raise Breast Cancer Risk 7733 3
...International Conference on Avian,Influenza at Fra...ewswire-FirstCall/ -- Very low doses of,Novavax In...n,against a lethal challenge of live H5N1 viruses,...ay at the Second International,Conference on Avian... microgram doses of Novavax,s,virus-like particle ...
...and Treatment of Rare but Devastating,Condition , ...versity London,and the University of Leicester and...breakthrough in the treatment of a rare but,devast...nd young,people. , In a world first, the clinician...ready treated one patient with promising,results. ...
Other Medicine Technology:Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 2Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 2World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 3World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 5
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications.
The link classic plus hip stem for cemented primary hip replacement surgery
The uncemented hip joint prosthesis system.
The cemented hip joint prosthesis system.
Medicine Products: